Lung cancer
Last updated: 01 November 2019
You can legally access new medicines, even if they are not approved in your country.
Learn more »
Following an earlier negative decision, NICE is now recommending NHS use of Roche’s immunotherapy Tecentriq for lung cancer.
Read more
